-
TrovaGene Down 40% Following Termination Of CEO, CFO
Tuesday, March 29, 2016 - 8:01am | 166Shares of TrovaGene Inc (NASDAQ: TROV) were trading lower by more than 40 percent early Tuesday morning after the company announced the termination of its CEO and CFO for cause. TrovaGene announced after Monday's market close that its Board of Directors terminated the employment of its CEO...